Literature DB >> 33457379

Pulmonary Hypertension in COVID-19 Pneumoniae: It Is Not Always as It Seems.

Maria Cristina Pasqualetto1, Maria Domenica Sorbo1, Maria Vitiello2, Chiara Ferrara2, Moreno Scevola2, Fabio Pantalone3, Fabio Gelain3, Claudio Aloi4, Manuele Nizzetto4, Fausto Rigo1.   

Abstract

A patient affected by COVID-19 pneumonia may develop pulmonary hypertension (PH) and secondary right ventricular (RV) involvement, due to lung parenchymal and interstitial damage and altered pulmonary haemodynamics, even in non-advanced phases of the disease. This is a consequence of hypoxic vasoconstriction of the pulmonary circulation, the use of positive end-expiratory pressure (PEEP) in mechanical ventilation, pulmonary endothelial injury, and local inflammatory thrombotic and/or thromboembolic processes. We report the case of a young man admitted with a diagnosis of COVID-19 pneumoniae with PH unrelated to viral infection and in whom partial anomalous pulmonary venous drainage (PAPVD) was eventually diagnosed. LEARNING POINTS: COVID-19 patients, even if previously well, can have pulmonary hypertension due to other causes.The cause of pulmonary hypertension should always be sought and not assumed, even in COVID-19 patients. © EFIM 2020.

Entities:  

Keywords:  COVID-19; partial anomalous pulmonary venous drainage; pulmonary hypertension; right ventricular involvement

Year:  2020        PMID: 33457379      PMCID: PMC7806283          DOI: 10.12890/2020_002160

Source DB:  PubMed          Journal:  Eur J Case Rep Intern Med        ISSN: 2284-2594


  9 in total

1.  Reevaluation of hemodynamic consequences of positive pressure ventilation: emphasis on cyclic right ventricular afterloading by mechanical lung inflation.

Authors:  F Jardin; G Delorme; A Hardy; B Auvert; A Beauchet; J P Bourdarias
Journal:  Anesthesiology       Date:  1990-06       Impact factor: 7.892

2.  Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis.

Authors:  Fabio Ciceri; Luigi Beretta; Anna Mara Scandroglio; Sergio Colombo; Giovanni Landoni; Annalisa Ruggeri; Jacopo Peccatori; Armando D'Angelo; Francesco De Cobelli; Patrizia Rovere-Querini; Moreno Tresoldi; Lorenzo Dagna; Alberto Zangrillo
Journal:  Crit Care Resusc       Date:  2020-04-15       Impact factor: 2.159

Review 3.  Hypoxic pulmonary vasoconstriction.

Authors:  J T Sylvester; Larissa A Shimoda; Philip I Aaronson; Jeremy P T Ward
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 46.500

4.  Endothelial cell infection and endotheliitis in COVID-19.

Authors:  Zsuzsanna Varga; Andreas J Flammer; Peter Steiger; Martina Haberecker; Rea Andermatt; Annelies S Zinkernagel; Mandeep R Mehra; Reto A Schuepbach; Frank Ruschitzka; Holger Moch
Journal:  Lancet       Date:  2020-04-21       Impact factor: 79.321

5.  Clinical Characteristics of Coronavirus Disease 2019 in China.

Authors:  Wei-Jie Guan; Zheng-Yi Ni; Yu Hu; Wen-Hua Liang; Chun-Quan Ou; Jian-Xing He; Lei Liu; Hong Shan; Chun-Liang Lei; David S C Hui; Bin Du; Lan-Juan Li; Guang Zeng; Kwok-Yung Yuen; Ru-Chong Chen; Chun-Li Tang; Tao Wang; Ping-Yan Chen; Jie Xiang; Shi-Yue Li; Jin-Lin Wang; Zi-Jing Liang; Yi-Xiang Peng; Li Wei; Yong Liu; Ya-Hua Hu; Peng Peng; Jian-Ming Wang; Ji-Yang Liu; Zhong Chen; Gang Li; Zhi-Jian Zheng; Shao-Qin Qiu; Jie Luo; Chang-Jiang Ye; Shao-Yong Zhu; Nan-Shan Zhong
Journal:  N Engl J Med       Date:  2020-02-28       Impact factor: 91.245

6.  Deciphering a case of pulmonary hypertension in a young female: Partial anomalous pulmonary venous drainage the culprit.

Authors:  Hiten R Patel; Suchit Bhutani; Fayez Shamoon; Hartaj Virk
Journal:  Ann Thorac Med       Date:  2018 Jan-Mar       Impact factor: 2.219

7.  Analysis of cardiopulmonary findings in COVID-19 fatalities: High incidence of pulmonary artery thrombi and acute suppurative bronchopneumonia.

Authors:  Claudia Grosse; Alexandra Grosse; Helmut J F Salzer; Martin W Dünser; Reinhard Motz; Rupert Langer
Journal:  Cardiovasc Pathol       Date:  2020-07-16       Impact factor: 2.185

8.  Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer.

Authors:  Sufang Tian; Weidong Hu; Li Niu; Huan Liu; Haibo Xu; Shu-Yuan Xiao
Journal:  J Thorac Oncol       Date:  2020-02-28       Impact factor: 15.609

9.  Pulmonary hypertension and right ventricular involvement in hospitalised patients with COVID-19.

Authors:  Matteo Pagnesi; Luca Baldetti; Alessandro Beneduce; Francesco Calvo; Mario Gramegna; Vittorio Pazzanese; Giacomo Ingallina; Antonio Napolano; Renato Finazzi; Annalisa Ruggeri; Silvia Ajello; Giulio Melisurgo; Paolo Guido Camici; Paolo Scarpellini; Moreno Tresoldi; Giovanni Landoni; Fabio Ciceri; Anna Mara Scandroglio; Eustachio Agricola; Alberto Maria Cappelletti
Journal:  Heart       Date:  2020-07-16       Impact factor: 5.994

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.